NCT07441694 2026-04-15
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Incyte Corporation
Phase 1 Recruiting
Incyte Corporation
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
Prelude Therapeutics
University of Southern California
Italfarmaco
University Hospital, Brest